Saxena A, Alport E C, Custead S, Skinnider L F
Department of Pathology, Royal University Hospital, University of Saskatchewan, Saskatoon, Canada.
J Pathol. 1999 Sep;189(1):79-84. doi: 10.1002/(SICI)1096-9896(199909)189:1<79::AID-PATH366>3.0.CO;2-C.
Angiomyolipoma, which consists of three intimately intermixed components, smooth muscle, blood vessels, and adipose tissue, is variably considered a hamartoma, a choristoma or a true neoplasm. This study has investigated the clonality of sporadic angiomyolipomas in seven women, each with a single lesion, by determining the pattern of X-chromosome inactivation. Polymerase chain reaction (PCR) amplification of the highly polymorphic human androgen receptor gene (HUMARA) was performed on the DNA extracted from the paraffin-embedded lesional tissue microdissected to sample the admixed smooth muscle and blood vessel component (SMC/BV) and the adipose tissue component. All seven patients were heterozygous for HUMARA polymorphism upon amplification of undigested DNA from non-lesional tissue and were therefore informative for further analysis. In all patients, lesional DNA, representative of the components, was predigested with HpaII restriction enzyme for amplification of the methylated allele. In six patients, the lesions were clonal, while in one, polyclonal. The polyclonal lesion was small and had less than 20 per cent SMC/BV component. Microdissected SMC/BV component was clonal in 6/7 lesions; the scanty SMC/BV in the remaining lesion did not yield amplifiable DNA. Microdissected adipose tissue was polyclonal in all seven lesions. Angiomyolipomas are three clonal lesions due to a clonal smooth muscle cell and blood vessel component, while the polyclonal adipose tissue is probably metaplastic or reactive.
血管平滑肌脂肪瘤由平滑肌、血管和脂肪组织三种紧密混合的成分组成,在不同程度上被认为是错构瘤、迷离瘤或真性肿瘤。本研究通过确定X染色体失活模式,调查了7名患有单个病变的女性散发性血管平滑肌脂肪瘤的克隆性。对从石蜡包埋的病变组织中提取的DNA进行聚合酶链反应(PCR)扩增,该病变组织经显微切割以获取混合的平滑肌和血管成分(SMC/BV)以及脂肪组织成分。对来自非病变组织的未消化DNA进行扩增后,所有7名患者的HUMARA多态性均为杂合子,因此可用于进一步分析。在所有患者中,代表各成分的病变DNA先用HpaII限制性内切酶进行预消化,以扩增甲基化等位基因。6名患者的病变为克隆性,1名患者为多克隆性。多克隆病变较小,SMC/BV成分少于20%。在7个病变中的6个中,显微切割的SMC/BV成分是克隆性的;其余病变中稀少的SMC/BV未产生可扩增的DNA。在所有7个病变中,显微切割的脂肪组织都是多克隆性的。血管平滑肌脂肪瘤是由于克隆性平滑肌细胞和血管成分形成的三种克隆性病变,而多克隆性脂肪组织可能是化生或反应性的。